News brief
On September 22, 2026, Suzhou-based Yunhe Zhiyao, a biopharmaceutical developer, completed an equity investment from Guanghua Wutong, Xiaochi Capital, Wutong Juyun and Ruishang Pharma.
Connected profiles
Explore
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2026年9月22日，据公开报道，苏州生物医药研发商云合智药完成股权投资，光华梧桐、晓池资本、梧桐聚云企管、瑞尚医药参与。公司专注生物医药研发。